Production (Stage)
MediXall Group, Inc.
MDXL
$0.0039
$0.000411.43%
OTC PK
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 44.27% | -8.39% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 44.27% | -8.39% | |||
| Cost of Revenue | 79.16% | -8.89% | |||
| Gross Profit | -93.56% | 9.10% | |||
| SG&A Expenses | -5.85% | -7.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 14.63% | -8.00% | |||
| Operating Income | -12.40% | 7.96% | |||
| Income Before Tax | -60.17% | 7.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -60.17% | 7.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -60.17% | 7.28% | |||
| EBIT | -12.40% | 7.96% | |||
| EBITDA | -9.44% | 7.97% | |||
| EPS Basic | -53.95% | 8.43% | |||
| Normalized Basic EPS | -62.79% | 10.42% | |||
| EPS Diluted | -17.00% | 0.00% | |||
| Normalized Diluted EPS | -62.79% | 10.42% | |||
| Average Basic Shares Outstanding | 0.03% | 2.38% | |||
| Average Diluted Shares Outstanding | 0.03% | 2.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||